BlackRock Fund Advisors - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 35 filers reported holding CANCER GENETICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2016$51,000
-20.3%
37,660
+2.4%
0.00%
Q3 2016$64,000
-12.3%
36,774
-0.2%
0.00%
Q2 2016$73,000
+12.3%
36,862
+60.6%
0.00%
Q1 2016$65,000
-19.8%
22,957
-6.4%
0.00%
Q4 2015$81,000
-55.0%
24,525
+6.4%
0.00%
Q3 2015$180,000
-13.9%
23,041
+29.4%
0.00%
Q2 2015$209,000
+71.3%
17,805
+13.6%
0.00%
Q1 2015$122,000
+90.6%
15,673
+63.6%
0.00%
Q4 2014$64,000
+68.4%
9,579
+127.9%
0.00%
Q3 2014$38,0004,2030.00%
Other shareholders
CANCER GENETICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
DOMINI IMPACT INVESTMENTS LLC 30,048$235,0003.84%
Millrace Asset Group, Inc. 198,774$1,554,0001.67%
EAM Investors, LLC 129,972$1,016,0000.16%
TURNER INVESTMENTS LLC 94,730$741,0000.15%
Granite Investment Partners, LLC 156,993$1,227,0000.12%
Sterneck Capital Management, LLC 20,030$157,0000.10%
DIKER MANAGEMENT LLC 28,815$225,0000.05%
ARDSLEY ADVISORY PARTNERS LP 15,000$117,0000.03%
VANGUARD GROUP INC 4,972,880$172,109,0000.01%
DENVER INVESTMENT ADVISORS LLC 14,141$111,0000.01%
View complete list of CANCER GENETICS INC shareholders